Inverse PPARβ/δ agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasion
about
Lipid-sensors, enigmatic-orphan and orphan nuclear receptors as therapeutic targets in breast-cancerFatty acid-binding protein 5 function in hepatocellular carcinoma through induction of epithelial-mesenchymal transition.Genetic ablation of the fatty acid-binding protein FABP5 suppresses HER2-induced mammary tumorigenesis.Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cellsTranscriptional response in normal mouse tissues after i.v. (211)At administration - response related to absorbed dose, dose rate, and timeIntegrative and systemic approaches for evaluating PPARβ/δ (PPARD) function.AMP-Activated Protein Kinase Interacts with the Peroxisome Proliferator-Activated Receptor Delta to Induce Genes Affecting Fatty Acid Oxidation in Human Macrophages.The Mycoplasma hyorhinis p37 Protein Rapidly Induces Genes in Fibroblasts Associated with Inflammation and Cancer.Deregulation of PPARβ/δ target genes in tumor-associated macrophages by fatty acid ligands in the ovarian cancer microenvironment.Establishing the Role of PPARβ/δ in CarcinogenesisInhibition of testicular embryonal carcinoma cell tumorigenicity by peroxisome proliferator-activated receptor-β/δ- and retinoic acid receptor-dependent mechanismsPPAR-delta promotes survival of breast cancer cells in harsh metabolic conditionsMetastasis regulation by PPARD expression in cancer cells.Src is activated by the nuclear receptor peroxisome proliferator-activated receptor β/δ in ultraviolet radiation-induced skin cancer.Therapeutic use of selective synthetic ligands for retinoic acid receptors: a patent review.The transcriptional PPARβ/δ network in human macrophages defines a unique agonist-induced activation state.Design and Synthesis of Highly Active Peroxisome Proliferator-Activated Receptor (PPAR) β/δ Inverse Agonists with Prolonged Cellular Activity.Suppression of PPARβ, and DHA treatment, inhibit NaV1.5 and NHE-1 pro-invasive activities.Angiopoietin-like 4 Modifies the Interactions between Lipoprotein Lipase and Its Endothelial Cell Transporter GPIHBP1.Cross-enhancement of ANGPTL4 transcription by HIF1 alpha and PPAR beta/delta is the result of the conformational proximity of two response elementsObesity and Breast Cancer: Current Insights on the Role of Fatty Acids and Lipid Metabolism in Promoting Breast Cancer Growth and Progression.Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer.Non-classical Transcriptional Activity of Retinoic Acid.The Anticancer Potential of Peroxisome Proliferator-Activated Receptor Antagonists.Colorectal cancer prognosis and PPARδ/β expression in the tumor microenvironment.
P2860
Q26764743-E0E8AA19-238B-4C8E-AF4D-2BA510DDB9ECQ33679605-C1A7F45C-C702-495C-97EC-EB4C3BC4140FQ33850093-9C6A664C-950C-4A66-8F3E-67BC5B317FC4Q34317168-1E20AF6A-8BC4-44D3-AC9C-3C7995B4908FQ35261291-D9B1FF96-6B46-4B59-A302-13F4D4613443Q35569436-3EAC74E8-52B0-4741-95C7-4F05D36A49FCQ35670860-E2397ADE-36E6-47A3-B232-167EA9342D81Q35825790-4C09231E-2C99-4BF7-8A73-DBD60D141979Q35955337-4DCCFD7E-8681-4622-8D13-B28C481B8A92Q36244704-8CDDF6D9-8090-4A60-ADBC-275047DD93B3Q36546655-96CACA03-3E24-443B-A284-9BD7C72CB56AQ37096225-F908EE72-B445-4923-A87F-9149188973CDQ37559645-4BE7B7C3-F050-41C2-B2D3-388FF7D0E899Q37606432-3921AA8D-7F8C-4D86-9383-4E83DF55F01FQ38874309-0DE0BBA1-E7D3-4C31-9D0D-3C85A9154060Q38879903-F70DCA64-BC89-4CBD-B05D-A75D43E04F8CQ38909807-D99D5B8B-7F97-4BC3-8E02-707B66A71D24Q38975907-F9828412-5252-4641-A120-EDC60F4307B7Q40431221-0A850EA3-5A29-4EC0-987C-A176B5B2BD5AQ40587087-F7A65EFF-460A-4423-B3DF-C3945388F199Q45000100-F05DA722-A6E5-416C-A248-E487E922FF00Q47699400-3CBE1DE5-69E5-40DC-B7A5-3B819AAC0053Q48070294-A3194D71-05D4-4642-802E-AF32E434D56AQ48350605-E4F34592-A571-46DA-8335-147F4EF18D8FQ53081525-EAD18FDC-08CC-49B2-B81C-5709711F486F
P2860
Inverse PPARβ/δ agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasion
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Inverse PPARβ/δ agonists suppr ...... d inhibit cancer cell invasion
@ast
Inverse PPARβ/δ agonists suppr ...... d inhibit cancer cell invasion
@en
Inverse PPARβ/δ agonists suppr ...... d inhibit cancer cell invasion
@nl
type
label
Inverse PPARβ/δ agonists suppr ...... d inhibit cancer cell invasion
@ast
Inverse PPARβ/δ agonists suppr ...... d inhibit cancer cell invasion
@en
Inverse PPARβ/δ agonists suppr ...... d inhibit cancer cell invasion
@nl
prefLabel
Inverse PPARβ/δ agonists suppr ...... d inhibit cancer cell invasion
@ast
Inverse PPARβ/δ agonists suppr ...... d inhibit cancer cell invasion
@en
Inverse PPARβ/δ agonists suppr ...... d inhibit cancer cell invasion
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Inverse PPARβ/δ agonists suppr ...... d inhibit cancer cell invasion
@en
P2093
D T Brandt
F Finkernagel
J Stockert
S Müller-Brüsselbach
P2860
P2888
P304
P3181
P356
10.1038/ONC.2012.549
P407
P577
2013-10-31T00:00:00Z
P5875
P6179
1037973162